Biotricity, Inc. BTCY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.40% | 14.80% | 10.19% | 18.95% | 21.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.40% | 14.80% | 10.19% | 18.95% | 21.00% |
| Cost of Revenue | -1.47% | 17.56% | -13.89% | -12.80% | -9.71% |
| Gross Profit | 13.28% | 14.13% | 17.64% | 29.37% | 31.89% |
| SG&A Expenses | 26.21% | -42.88% | -8.17% | 2.49% | -27.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.67% | -21.98% | -6.37% | 1.05% | -16.82% |
| Operating Income | -43.92% | 181.19% | 360.89% | 188.98% | 125.24% |
| Income Before Tax | -42.78% | 83.25% | 41.66% | 55.76% | 81.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -42.78% | 83.25% | 41.66% | 55.76% | 81.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.78% | 83.25% | 41.66% | 55.76% | 81.81% |
| EBIT | -43.92% | 181.19% | 360.89% | 188.98% | 125.24% |
| EBITDA | -43.68% | 181.50% | 364.12% | 189.91% | 125.41% |
| EPS Basic | -61.32% | 79.27% | 23.53% | 60.68% | 94.15% |
| Normalized Basic EPS | -60.49% | 84.63% | 47.28% | 62.82% | 88.93% |
| EPS Diluted | -61.32% | 79.27% | 23.53% | 60.54% | 94.15% |
| Normalized Diluted EPS | -60.49% | 84.63% | 47.28% | 62.82% | 88.93% |
| Average Basic Shares Outstanding | -12.13% | 8.42% | 13.86% | 19.00% | 85.50% |
| Average Diluted Shares Outstanding | -12.13% | 8.42% | 13.86% | 19.00% | 85.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.29% | -4.86% | -0.76% | -1.29% | -1.72% |